UPTEMPO Trademark

Trademark Overview


On Thursday, May 4, 2023, a trademark application was filed for UPTEMPO with the United States Patent and Trademark Office. The USPTO has given the UPTEMPO trademark a serial number of 97921045. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, September 27, 2024. This trademark is owned by CATALENT PHARMA SOLUTIONS, INC.. The UPTEMPO trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies

Cells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene ...

Cells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tu...

Pharmaceutical research and development; Gene therapy research; Cell therapy research; Scientific research
uptempo

General Information


Serial Number97921045
Word MarkUPTEMPO
Filing DateThursday, May 4, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, September 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Goods and ServicesCustom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies
Goods and ServicesCells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes
Goods and ServicesCells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for use in scientific research and analysis
Goods and ServicesPharmaceutical research and development; Gene therapy research; Cell therapy research; Scientific research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, June 4, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, June 4, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, June 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events


Event DateEvent Description
Monday, May 8, 2023NEW APPLICATION ENTERED
Sunday, June 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 20, 2023ASSIGNED TO EXAMINER
Thursday, December 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, April 3, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2024SOU EXTENSION 1 GRANTED
Friday, September 27, 2024SOU EXTENSION 1 FILED